The recent surge in capital into niche pharmaceutical companies, particularly those focusing on experimental therapies and challenging drug development programs, has fueled what some are calling "High Investor Pharma." https://pennydkuh483305.shoutmyblog.com/38997086/elite-roller-pharma-the-hazardous-wager